Syngeneic B16F10 Melanoma Causes Cachexia and Impaired Skeletal Muscle Strength and Locomotor Activity in Mice

Supplementation with l-glutamine prevents tumor growth and cancer-induced cachexia as well as restores cell proliferation of intestinal mucosa of Walker-256 tumor-bearing rats

(2016) Heber Amilcar Martins et al.   AMINO ACIDS

Cytokine Signaling in Skeletal Muscle Wasting

(2016) Jin Zhou et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016

(2016) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Prognostic score for patients with advanced melanoma treated with ipilimumab

(2015) Stefan Diem et al.   EUROPEAN JOURNAL OF CANCER

Tumor inoculation site affects the development of cancer cachexia and muscle wasting

(2015) Tatsuzo Matsuyama et al.   INTERNATIONAL JOURNAL OF CANCER

The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature

(2015) Savita Joglekar et al.   JOURNAL OF SURGICAL ONCOLOGY

Cancer as a Proinflammatory Environment: Metastasis and Cachexia

(2015) Nelson Inácio Pinto et al.   MEDIATORS OF INFLAMMATION

Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: An in vitro and in vivo study

(2015) LEI YUAN et al.   ONCOLOGY REPORTS

Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved

(2015) Ji-an Chen et al.   Journal of Cachexia Sarcopenia and Muscle

Pathophysiology of anorexia in the cancer cachexia syndrome

(2015) Chukwuemeka Charles Ezeoke et al.   Journal of Cachexia Sarcopenia and Muscle

Muscle dysfunction in cancer patients

(2014) J. F. Christensen et al.   ANNALS OF ONCOLOGY

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma

(2014) Sander Kelderman et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways

(2014) S J Allison et al.   Oncogenesis

Comparison of nutritional status assessment parameters in predicting length of hospital stay in cancer patients

(2013) J. Mendes et al.   CLINICAL NUTRITION

The Role of Inflammatory Pathways in Cancer-Associated Cachexia and Radiation Resistance

(2013) A. Laine et al.   MOLECULAR CANCER RESEARCH

Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia

(2013) Hirak Der-Torossian et al.   Journal of Cachexia Sarcopenia and Muscle

Integrative role of neuropeptides and cytokines in cancer anorexia–cachexia syndrome

(2012) Surajeet K. Patra et al.   CLINICA CHIMICA ACTA

TNFalpha- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism

(2012) Joffrey De Larichaudy et al.   Skeletal Muscle

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia

(2011) S. K. Das et al.   SCIENCE

Muscle Activity during Functional Coordination Training: Implications for Strength Gain and Rehabilitation

(2010) Marie B Jørgensen et al.   JOURNAL OF STRENGTH AND CONDITIONING RESEARCH

Mouse models for melanoma: a personal perspective

(2009) Jürgen C. Becker et al.   EXPERIMENTAL DERMATOLOGY

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE